Case number 1:21-cv-00900
Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 3, 2023 | 108 | STIPULATION TO EXTEND TIME for the Parties to Serve (1) Reply Expert Reports and (2) Sur-Reply Expert Reports on Secondary Considerations to July 21, 2023 and August 11, 2023, respectively - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Ewing, Alexandra) (Entered: 07/03/2023) (2) |
| Jun 20, 2023 | 106 | NOTICE OF SERVICE of (1) Expert Report of Ron. T. Gansevoort, M.D., Ph.D., (2) Expert Report of John C. Jarosz, and (3) Responsive Expert Report of William R. Roush, Ph.D., Regarding Validity of U.S. Patent Nos. 8,273,735 and 8,501,730 filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 06/20/2023) (3) |
| Jun 20, 2023 | 107 | NOTICE OF SERVICE of Responsive Expert Report of William Dichtel, Ph.D. Regarding Alleged Infringement of U.S. Patent Nos. 8,273,735 and 8,501,730 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 06/20/2023) (2) |
| Apr 28, 2023 | 105 | NOTICE OF SERVICE of Expert Report of William Dichtel, Ph.D. Regarding Invalidity of U.S. Patent Nos. 8,273,735 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 04/28/2023) (2) |
| Apr 19, 2023 | 104 | STIPULATION of Otsuka Pharmaceutical Co., Ltd., Lupin Limited, and Lupin Pharmaceuticals, Inc. by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Ewing, Alexandra) (Entered: 04/19/2023) (4) |
| Apr 18, 2023 | 103 | MOTION for Pro Hac Vice Appearance of Attorney Matthew Friedrichs - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick) (Entered: 04/18/2023) (3) |
| Apr 3, 2023 | 101 | NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs Second Set of Interrogatories (Nos. 18-19) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 04/03/2023) (2) |
| Apr 3, 2023 | 102 | NOTICE requesting Clerk to remove Andrew E. Morrell as co-counsel.. (Ewing, Alexandra) Modified on 4/4/2023 (nms). (Entered: 04/03/2023) (2) |
| Mar 31, 2023 | 100 | NOTICE OF SERVICE of Otsuka Pharmaceutical Co., Ltd.'s Responses and Objections to Defendants' Fourth Set of Interrogatories (Nos. 18-19) filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 03/31/2023) (3) |
| Mar 27, 2023 | 99 | NOTICE of of Change of Address for John D. Murnane, Joshua I. Rothman, Alicia A. Russo, and Zachary L. Garrett by Otsuka Pharmaceutical Co., Ltd. (Tigan, Jeremy) (Entered: 03/27/2023) (2) |
| Mar 21, 2023 | 98 | NOTICE OF SERVICE of Defendants' Second Supplemental Responses to Plaintiff's First Set of Interrogatories (Nos. 1, 2, 3, 4, 5, 8) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 03/21/2023) (2) |
| Mar 6, 2023 | 97 | NOTICE OF SERVICE of Otsuka Pharmaceutical Co., Ltd.'s Objections and Responses to Defendants' Notice of Rule 30(b)(6) Deposition filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 03/06/2023) (3) |
| Mar 2, 2023 | 96 | NOTICE OF SERVICE of Plaintiff's Second Set of Interrogatories to Defendants Lupin Limited and Lupin Pharmaceuticals Inc. (Nos. 18-19) filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 03/02/2023) (3) |
| Mar 1, 2023 | 95 | NOTICE OF SERVICE of Defendants' Fourth Set of Interrogatories (Nos. 18-19) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 03/01/2023) (2) |
| Feb 28, 2023 | 94 | NOTICE to Take Deposition of Lupin Limited and Lupin Pharmaceuticals, Inc. on April 7, 2023 filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 02/28/2023) (10) |
| Feb 27, 2023 | 86 | NOTICE to Take Deposition of Pramod Dahibhate on March 15, 2023 filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 02/27/2023) (3) |
| Feb 27, 2023 | 87 | NOTICE to Take Deposition of Girij P. Singh on March 20, 2023 filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 02/27/2023) (3) |
| Feb 27, 2023 | 88 | NOTICE to Take Deposition of Swapnil Jadhav on March 21, 2023 filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 02/27/2023) (3) |
| Feb 27, 2023 | 89 | NOTICE to Take Deposition of Malhari Bhor on April 3, 2023 filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 02/27/2023) (3) |
| Feb 27, 2023 | 90 | NOTICE to Take Deposition of Sonaraj Jangam on April 4, 2023 filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 02/27/2023) (3) |
| Feb 27, 2023 | 91 | NOTICE to Take Deposition of K. Bala Anki Reddy on April 5, 2023 filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 02/27/2023) (3) |
| Feb 27, 2023 | 92 | NOTICE to Take Deposition of Shailendra Pathak on April 6, 2023 filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 02/27/2023) (3) |
| Feb 27, 2023 | 93 | NOTICE to Take Deposition of Rajiv Shakya on April 7, 2023 filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 02/27/2023) (3) |
| Feb 24, 2023 | 85 | MOTION for Pro Hac Vice Appearance of Attorney Jared C. Bunker - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick) (Entered: 02/24/2023) (3) |
| Feb 23, 2023 | 76 | NOTICE to Take Deposition of Shigekazu Fujita on March 21, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 02/23/2023) (2) |
| Feb 23, 2023 | 77 | NOTICE to Take Deposition of Hirotaka Yukawa on March 22, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 02/23/2023) (2) |
| Feb 23, 2023 | 78 | NOTICE to Take Deposition of Naoto Utsumi on March 24, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 02/23/2023) (2) |
| Feb 23, 2023 | 79 | NOTICE to Take Deposition of Hidenori Ogawa on March 27, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 02/23/2023) (2) |
| Feb 23, 2023 | 80 | NOTICE to Take Deposition of Yasuaki Muguruma on March 28, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 02/23/2023) (2) |
| Feb 23, 2023 | 81 | NOTICE to Take Deposition of Kaoru Abe on March 29, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 02/23/2023) (2) |
| Feb 23, 2023 | 82 | NOTICE to Take Deposition of Yasuhiro Torisawa on March 30, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 02/23/2023) (2) |
| Feb 23, 2023 | 83 | NOTICE to Take Deposition of Masahiro Miyake on March 23, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 02/23/2023) (2) |
| Feb 23, 2023 | 84 | NOTICE OF SERVICE of Defendants' Notice of Deposition of Plaintiff Under Federal Rule of Civil Procedure 30(b)(6) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 02/23/2023) (2) |
| Jan 18, 2023 | 75 | NOTICE OF SERVICE of Plaintiff Otsuka Pharmaceutical Co., Ltd.'s First Supplemental Responses and Objections to Defendants' Interrogatories (Nos. 1, 2, 4, 6, 8, 9, 10, 12, 13, 17) filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 01/18/2023) (3) |
| Dec 30, 2022 | 74 | SO ORDERED Granting 73 Stipulation and Proposed Order Dismissing Otsuka's '694 Patent Claims Against Lupin and Lupin's Counterclaims Against the '694 Patent. Signed by Judge Richard G. Andrews on 12/30/2022. (nms) (Entered: 12/30/2022) (3) |
| Dec 29, 2022 | 73 | STIPULATION and [Proposed] Order Dismissing Otsuka's '694 Patent Claims Against Lupin and Lupin's Counterclaims Against the '694 Patent - by Otsuka Pharmaceutical Co., Ltd.. (Tigan, Jeremy) (Entered: 12/29/2022) (3) |
| Dec 21, 2022 | 72 | STIPULATION and [Proposed] Order to Amend Certain Scheduling Order Deadlines, by Otsuka Pharmaceutical Co., Ltd.. (Tigan, Jeremy) Modified on 12/21/2022 (nms). (Entered: 12/21/2022) (2) |
| Dec 16, 2022 | 71 | NOTICE OF SERVICE of Defendants' Supplemental Responses to Plaintiff's First Set of Interrogatories (Nos. 1, 4, & 9) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 12/16/2022) (2) |
| Oct 14, 2022 | 70 | NOTICE OF SERVICE of Plaintiff Otsuka Pharmaceutical Co., Ltd.'s Responses and Objections to Defendants' Third Set of Interrogatories (No. 17) filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 10/14/2022) (3) |
| Sep 29, 2022 | 69 | NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-17) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 09/29/2022) (2) |
| Sep 20, 2022 | 68 | STIPULATION and Proposed Order to Extend Time for the Substantial Completion of Document Production to October 21, 2022 - filed by Otsuka Pharmaceutical Co., Ltd.. (Tigan, Jeremy) Modified on 9/20/2022 (nms). (Entered: 09/20/2022) (1) |
| Sep 15, 2022 | 67 | NOTICE OF SERVICE of Plaintiff Otsuka Pharmaceutical Co., Ltd.'s Responses and Objections to Defendants' Second Set of Interrogatories (Nos. 12-16) filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) (Entered: 09/15/2022) (3) |
| Sep 14, 2022 | 66 | NOTICE OF SERVICE of Third Set of Interrogatories (No. 17) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 09/14/2022) (2) |
| Aug 17, 2022 | 63 | ORAL ORDER: The parties in No. 22-513 submitted a scheduling proposal (D.I. 17) wherein Defendant Teva requests the case be consolidated with the case against Lupin in No. 21-900. Tevas proposed schedule includes no Markman hearing (as the Markman hearing in Otsuka v. Lupin has already been held and resolved), and trial on the same date (Dec. 18, 2023) as the Otsuka v. Lupin trial. The Court would like to consolidate the two cases, but will not do so without first hearing from Lupin. The Court also notes that in both cases, launch appears to be prohibited until at the earliest April 2025 (No. 22-513, D.I. 17 at 11 n.4; No. 21-900, D.I. 16 at 10 n.3), meaning that there is flexibility in scheduling the trial. The Court requests that Teva submit a letter by COB today describing generally any conversations it has had with Lupin about consolidation. The Court requests that Lupin submit a letter by COB today setting forth its position on consolidation. (If Lupin needs more time to think about it, Lupin should say so.) Ordered by Judge Richard G. Andrews on 8/17/2022. Associated Cases: 1:22-cv-00513-RGA, 1:21-cv-00900-RGA(nms) (Entered: 08/17/2022) (0) |
| Aug 17, 2022 | 64 | Official Transcript of Markman Hearing held on 7/1/22 before Judge Richard G. Andrews. Court Reporter Deanna Warner,Email: Warnerdeanna@gmail.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/7/2022. Redacted Transcript Deadline set for 9/19/2022. Release of Transcript Restriction set for 11/15/2022. (Triozzi, Heather) (Entered: 08/17/2022) (107) |
| Aug 17, 2022 | 65 | Letter to The Honorable Richard G. Andrews, from Frederick L. Cottrell, III, regarding action consolidation. (Cottrell, Frederick) Modified on 8/18/2022 (nms). (Entered: 08/17/2022) (2) |
| Jul 29, 2022 | 62 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's First Set of Interrogatories to Defendants Lupin Limited and Lupin Pharmaceuticals Inc. (Nos. 1-17) filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) |
| Jul 26, 2022 | 61 | Memorandum Opinion (10) Docket Text: MEMORANDUM OPINION providing claim construction for multiple terms in U.S. Patent Nos. 8,501,730 and U.S. Patent No. 10,905,694. Signed by Judge Richard G. Andrews on 7/26/2022. (nms) |
| Jul 14, 2022 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendents Lupin Limited and Lupin Pharmaceuticals, Inc.'s Second Set of Interrogatories (Nos. 12-16) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
| Jul 1, 2022 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 7/1/2022. Local Counsel present for Plaintiff: J. Tigan. Local Counsel present for Defendants: F. Cottrell. (Court Reporter Deanna Warner.) (nms) |
| Jun 10, 2022 | 58 | Redacted Document (30) Docket Text: REDACTED VERSION of [53] Joint Claim Construction Brief by Otsuka Pharmaceutical Co., Ltd.. (Tigan, Jeremy) |
| Jun 10, 2022 | 59 | Main Document (4) Docket Text: REDACTED VERSION of [56] Appendix, Volume 3, by Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibits Q-Z, # (2) Exhibits AA-FF)(Tigan, Jeremy) Modified on 6/10/2022 (nms). |
| Jun 10, 2022 | 59 | Exhibits Q-Z (199) |
| Jun 10, 2022 | 59 | Exhibits AA-FF (332) |
| Jun 3, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Due to a scheduling conflict the Markman hearing scheduled for 6/28/2022, is CANCELED. The Markman Hearing is now reset for 7/1/2022, at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 6/3/2022. (nms) |
| Jun 3, 2022 | 52 | Motion for Miscellaneous Relief (3) Docket Text: Joint Motion for Claim Construction - filed by Otsuka Pharmaceutical Co., Ltd.. (Tigan, Jeremy) Modified on 6/3/2022 (nms). |
| Jun 3, 2022 | 54 | Main Document (4) Docket Text: Joint Appendix, Volume 1 of 3 re [53] Joint Claim Construction Brief, by Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Declarations and Exhibits A-K)(Tigan, Jeremy) Modified on 6/3/2022 (nms). |
| Jun 3, 2022 | 54 | Declarations and Exhibits A-K (584) |
| Jun 3, 2022 | 55 | Main Document (4) Docket Text: Joint Appendix, Volume 2 of 3 re [53] Joint Claim Construction Brief, by Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibits L-P)(Tigan, Jeremy) Modified on 6/3/2022 (nms). |
| Jun 3, 2022 | 55 | Exhibits L-P (826) |
| Jun 3, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Joint Motion for Claim Construction (D.I. [52]) is GRANTED. The argument will be limited to two hours in total, to be divided equally between the parties. Ordered by Judge Richard G. Andrews on 6/3/2022. (nms) |
| Jun 1, 2022 | 50 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
| May 11, 2022 | 49 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Otsuka Pharmaceutical Co., Ltd.'s Reply Claim Construction Brief; (2) Declaration of William R. Roush, Ph.D. in Support of Plaintiff Otsuka Pharmaceutical Co., Ltd.'s Reply Claim Construction Brief; and (3) Declaration of Robert O. Williams III, Ph.D. in Support of Plaintiff Otsuka Pharmaceutical Co., Ltd.'s Reply Claim Construction Brief filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) |
| May 4, 2022 | 48 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant/Counterclaimant's Initial Invalidity Contentions Concerning U.S. Patent 8,273,735 and Appendix 3: '735 Patent Invalidity Claim Chart for Asserted Caims filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
| Apr 29, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [47] STIPULATION TO EXTEND TIME for (1) Plaintiff Otsuka Pharmaceutical Co., Ltd. to serve its Reply Claim Construction Brief and (2) Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. to serve their Sur-Reply Claim Construction Brief. Signed by Judge Richard G. Andrews on 4/29/2022. (nms) |
| Apr 29, 2022 | 47 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for (1) Plaintiff Otsuka Pharmaceutical Co., Ltd. to serve its Reply Claim Construction Brief and (2) Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. to serve their Sur-Reply Claim Construction Brief to May 11, 2022 and June 1, 2022, respectively - filed by Otsuka Pharmaceutical Co., Ltd.. (Tigan, Jeremy) |
| Apr 20, 2022 | 46 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Answering Claim Construction Brief filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
| Apr 13, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Hall for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (ceg) |
| Apr 8, 2022 | 45 | Answer to Counterclaim (17) Docket Text: ANSWER to [41] Answer to Amended Complaint, Counterclaim by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) |
| Apr 6, 2022 | 44 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Otsuka Pharmaceutical Co., Ltd.'s Responses and Objections to Defendants' First Set of Interrogatories (Nos. 1-11) filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) |
| Apr 5, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [43] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Otsuka Pharmaceutical Co., Ltd. answer due 4/11/2022). Signed by Judge Richard G. Andrews on 4/5/2022. (nms) |
| Apr 4, 2022 | 42 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Otsuka Pharmaceutical Co., Ltd.'s Initial Infringement Contentions filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) |
| Apr 4, 2022 | 43 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Otsuka Pharmaceutical Co., Ltd.. (Tigan, Jeremy) Modified on 4/5/2022 (nms). |
| Mar 21, 2022 | 41 | Answer to Amended Complaint (30) Docket Text: ANSWER to [37] Amended Complaint and Amended COUNTERCLAIMS against Otsuka Pharmaceutical Co., Ltd., by Lupin Limited, Lupin Pharmaceuticals, Inc..(Cottrell, Frederick) Modified on 3/21/2022 (nms). |
| Mar 18, 2022 | 40 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Otsuka Pharmaceutical Co., Ltd.'s Opening Claim Construction Brief filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) |
| Mar 7, 2022 | 37 | Main Document (12) Docket Text: First Amended Complaint for Patent Infringement against Lupin Limited, Lupin Pharmaceuticals, Inc. - filed by Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Tigan, Jeremy) Modified on 3/7/2022 (nms). |
| Mar 7, 2022 | 37 | Exhibit A (18) |
| Mar 7, 2022 | 37 | Exhibit B (15) |
| Mar 7, 2022 | 37 | Exhibit C (18) |
| Mar 7, 2022 | 38 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,501,730 B2; 10,905,694 B2; 8,273,735 B2. (Tigan, Jeremy) Modified on 3/8/2022 (nms). |
| Mar 7, 2022 | 39 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants First Set of Interrogatories (Nos. 1-11) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
| Mar 7, 2022 | 37 | Amended Complaint* (1) |
| Mar 4, 2022 | 35 | Main Document (4) Docket Text: Unopposed Motion for Leave to File First Amended Complaint - filed by Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Tigan, Jeremy) Modified on 3/4/2022 (nms). |
| Mar 4, 2022 | 35 | Exhibit A (13) |
| Mar 4, 2022 | 35 | Exhibit B (13) |
| Mar 4, 2022 | 36 | Order (1) Docket Text: ORDER Granting [35] Unopposed Motion for Leave to File First Amended Complaint. Signed by Judge Richard G. Andrews on 3/4/2022. (nms) |
| Feb 18, 2022 | 34 | Main Document (15) Docket Text: Joint Claim Construction Chart, by Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibits A-C, # (2) Exhibits D-E)(Tigan, Jeremy) Modified on 2/21/2022 (nms). |
| Feb 18, 2022 | 34 | Exhibits A-C (1366) |
| Feb 18, 2022 | 34 | Exhibits D-E (409) |
| Feb 7, 2022 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Disclosure of Proposed Claim Terms filed by Otsuka Pharmaceutical Co., Ltd..(Blumenfeld, Jack) |
| Feb 4, 2022 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Disclosure of Proposed Claim Terms and Their Proposed Constructions filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
| Jan 25, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [31] MOTION for Pro Hac Vice Appearance of Attorney John D. Murnane, Joshua I. Rothman, Alicia A. Russo and Zachary L. Garrett, filed by Otsuka Pharmaceutical Co., Ltd.. Signed by Judge Richard G. Andrews on 1/25/2022. (nms) |
| Jan 24, 2022 | 31 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney John D. Murnane, Joshua I. Rothman, Alicia A. Russo and Zachary L. Garrett - filed by Otsuka Pharmaceutical Co., Ltd.. (Tigan, Jeremy) |
| Jan 21, 2022 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant/Counterclaimant Lupin Limited and Defendant Lupin Pharmaceuticals, Inc.'s Initial Invalidity Contentions filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
| Dec 27, 2021 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Objections and Responses to Plaintiff's First Set of Requests for Production of Documents and Things (Nos. 1-66) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
| Dec 22, 2021 | 28 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions filed by Otsuka Pharmaceutical Co., Ltd..(Blumenfeld, Jack) |
| Dec 13, 2021 | 27 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Supplemental Responses to Defendants' First Set of Requests for Production of Documents and Things (Nos. 1-126) filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) |
| Nov 30, 2021 | 26 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Otsuka Pharmaceutical Co., Ltd.'s First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-66) - filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) |
| Nov 29, 2021 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Responses to Defendants' First Set of Requests for Production of Documents and Things (Nos. 1-126) filed by Otsuka Pharmaceutical Co., Ltd..(Blumenfeld, Jack) |
| Nov 23, 2021 | 24 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Plaintiff's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Otsuka Pharmaceutical Co., Ltd..(Blumenfeld, Jack) |
| Nov 22, 2021 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Lupin Limited and Lupin Pharmaceuticals, Inc.'s: (1) Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
| Nov 12, 2021 | 22 | Order (29) Docket Text: SO ORDERED Granting [20] Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 11/12/2021. (nms) |
| Nov 10, 2021 | 20 | Proposed Order (29) Docket Text: PROPOSED Protective Order, by Otsuka Pharmaceutical Co., Ltd.. (Tigan, Jeremy) Modified on 11/10/2021 (nms). |
| Nov 10, 2021 | 21 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Disclosures Pursuant to District of Delaware Default Standard for Discovery Paragraph 4(a) filed by Otsuka Pharmaceutical Co., Ltd..(Tigan, Jeremy) |
| Oct 28, 2021 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants First Set of Requests for Production of Documents and Things (Nos. 1-126) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
| Oct 25, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Jennifer L. Hall for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel) |
| Oct 25, 2021 | 15 | Main Document (11) Docket Text: PROPOSED Scheduling Order, by Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Letter)(Blumenfeld, Jack) Modified on 10/25/2021 (nms). |
| Oct 25, 2021 | 15 | Letter to The Honorable Richard G. Andrews (1) |
| Oct 25, 2021 | 16 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 5/15/2022. Amended Pleadings due by 5/15/2022. Fact Discovery completed by 2/10/2023. Joint Claim Construction Brief due by 6/3/2022. A Markman Hearing is set for 6/28/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 12/8/2023, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 12/18/2023, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 10/25/2021. (nms) |
| Oct 25, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference scheduled for 10/27/2021, is CANCELED. Ordered by Judge Richard G. Andrews on 10/25/2021. (nms) |
| Oct 25, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If, during the pendency of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Hall, they should contact chambers by e-mail at Cailah_Garfinkel@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Hall regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. In addition, Judge Hall may in the future enter a sua sponte order setting an ADR teleconference. ORDERED by Judge Jennifer L. Hall on 10/25/2021. (ceg) |
| Sep 28, 2021 | 14 | Answer to Counterclaim (6) Docket Text: ANSWER to [9] Answer to Complaint, and Counterclaims, by Otsuka Pharmaceutical Co., Ltd..(Blumenfeld, Jack) Modified on 9/28/2021 (nms). |
| Sep 10, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Carol M. Pitzel Cruz, Andrew E. Morrell, William R. Zimmerman for Lupin Limited, Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Sep 10, 2021 | 13 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 10/27/2021, at 9:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/10/2021. (nms) |
| Sep 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Andrew E. Morrell, and Carol Pitzel Cruz, filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 9/8/2021. (nms) |
| Sep 8, 2021 | 12 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Alexandra M. Ewing on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Ewing, Alexandra) |
| Sep 7, 2021 | 9 | Answer to Complaint (21) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses and COUNTERCLAIMS against Otsuka Pharmaceutical Co., Ltd., by Lupin Limited, Lupin Pharmaceuticals, Inc..(Cottrell, Frederick) Modified on 9/7/2021 (nms). |
| Sep 7, 2021 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick) |
| Sep 7, 2021 | 11 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Andrew E. Morrell, and Carol Pitzel Cruz - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick) |
| Jul 8, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Otsuka Pharmaceutical Co., Ltd.: For Lupin Pharmaceuticals, Inc. waiver sent on 7/7/2021, answer due 9/7/2021. (Blumenfeld, Jack) |
| Jul 8, 2021 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Otsuka Pharmaceutical Co., Ltd.: For Lupin Limited waiver sent on 7/7/2021, answer due 9/7/2021. (Blumenfeld, Jack) |
| Jun 30, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jun 24, 2021 | 6 | Main Document (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (Attachments: # (1) Summons- Lupin Pharma)(smg) |
| Jun 24, 2021 | 6 | Summons- Lupin Pharma (2) |
| Jun 23, 2021 | 1 | Main Document (11) Docket Text: COMPLAINT for PATENT INFRINGEMENT- filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3642051.) - filed by Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet)(smg) Modified on 6/24/2021 (smg). |
| Jun 23, 2021 | 1 | Exhibit A (18) |
| Jun 23, 2021 | 1 | Exhibit B (15) |
| Jun 23, 2021 | 1 | Civil Cover Sheet (2) |
| Jun 23, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) |
| Jun 23, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 11, 2021. Date of Expiration of the '730 Patent: September 1, 2026 Date of Expiration of the '694 Patent: April 7, 2030.Thirty Month Stay Deadline: 11/11/2023. (smg) Modified on 6/24/2021 (smg). |
| Jun 23, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,501,730 ; 10,905,694. (smg) |
| Jun 23, 2021 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (smg) |
| Jun 23, 2021 | 1 | Complaint* (1) |
